Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2026-03-04 @ 2:28 PM
Study NCT ID:
NCT02685033
Status:
COMPLETED
Last Update Posted:
2019-01-04
First Post:
2016-02-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
Sponsor:
Durata Therapeutics Inc., an affiliate of Allergan plc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DAL-MD-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None